AFZAAL IQBAL: Open Payments
NPI 1861782674 · FOUNTAIN VALLEY, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$971 in 44 payments from 14 companies in 2025. Trend: 2023 $432 · 2024 $1,677 · 2025 $971
Food & beverage: $971
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 12 | $270 |
| Boston Scientific Corporation | 11 | $229 |
| Collegium Pharmaceutical, Inc. | 8 | $143 |
| Axsome Therapeutics, Inc. | 2 | $64 |
| Globus Medical, Inc. | 2 | $60 |
| BIOTRONIK NRO, Inc. | 1 | $36 |
| Lilly USA, LLC | 1 | $30 |
| DePuy Synthes Sales Inc. | 1 | $28 |
| Spinal Simplicity, LLC | 1 | $24 |
| Curonix LLC | 1 | $20 |
Products named: WaveWriter Alpha Prime 16, Belbuca, QULIPTA, BOTOX, UBRELVY, Symbravo, Senza, Prospera.
Industry payments across CA — which companies pay providers there.
